Patent details

EP2322556 Title: Humanized anti-beta7 antagonists and uses therefor

Basic Information

Publication number:
EP2322556
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP101774073
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Humanized anti-beta7 antagonists and uses therefor
French Title of Invention:
Antagonistes anti-béta 7 humanisés et utilisations associées
German Title of Invention:
Humanisierte Anti-Beta-7-Antagonisten und deren Verwendung
SPC Number:

Dates

Filing date:
02/09/2005
Grant date:
21/10/2015
EP Publication Date:
21/10/2015
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
18/05/2011
EP B1 Publication Date:
21/10/2015
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
02/09/2023
Expiration date:
02/09/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
02/09/2005
 
 

Name:
Genentech Inc.
Address:
1 DNA Way, South San Francisco, CA 94080-4990, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
18/11/2015
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
Dennis Mark, S.
Address:
United States (US)

2

Name:
Fong Sherman
Address:
United States (US)

Priority

Priority Number:
607377 P
Priority Date:
03/09/2004
Priority Country:
United States (US)

Classification

Main IPC Class:
C07K 16/28;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
10/08/2022
Last Annual Fee Paid Number:
18
Last Annual Fee Paid Amount:
262 Euro
Payer:
MASTER DATA CENTER INC (ex Clarivate Analytics)
Filing date Document type Number of pages